Strategic Investment: Premialab has secured a significant $220 million growth investment from KKR and existing investor Balderton, which will substantially enhance its competitive position in the $800 billion Quantitative Investment Strategies market.
Market Standard: Premialab has built a proprietary database featuring over 7,000 QIS strategies, establishing itself as the global standard for data, analytics, and risk management, thereby reinforcing its market leadership.
Accelerated Product Development: This investment will enable Premialab to accelerate product development, particularly in enhancing its execution offering co-developed with Eurex, improving client access to QIS strategies with greater transparency.
Global Expansion: KKR's investment will support Premialab's continued global expansion of core operational systems, enhancing collaborations with top investment banks and institutional investors, thereby driving future business growth.
KKR
$134.81+Infinity%1D
Analyst Views on KKR
Wall Street analysts forecast KKR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KKR is 157.20 USD with a low forecast of 145.00 USD and a high forecast of 188.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
Wall Street analysts forecast KKR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KKR is 157.20 USD with a low forecast of 145.00 USD and a high forecast of 188.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
0 Hold
0 Sell
Strong Buy
Current: 136.600
Low
145.00
Averages
157.20
High
188.00
Current: 136.600
Low
145.00
Averages
157.20
High
188.00
Barclays
Overweight
maintain
$154 -> $169
2025-12-12
New
Reason
Barclays
Price Target
$154 -> $169
2025-12-12
New
maintain
Overweight
Reason
Barclays raised the firm's price target on KKR to $169 from $154 and keeps an Overweight rating on the shares. The firm adjusted targets in the brokers, asset managers and exchanges group as part of its 2026. Market conditions "look constructive" going into 2026, particularly for the alternative asset managers and wealth brokers, the analyst tells investors in a research note. Barclays sees a more mixed outlook for the exchanges and traditional asset managers.
UBS
Buy
initiated
$176
2025-12-11
New
Reason
UBS
Price Target
$176
2025-12-11
New
initiated
Buy
Reason
UBS initiated coverage of KKR with a Buy rating and $176 price target. The firm views KKR as its preferred way to play a capital markets acceleration. The company's fundraising remains strong across its flagships funds, the analyst tells investors in a research note. UBS believes continued fundraising success and a capital markets rebound could drive multiple expansion in the shares.
Barclays
Benjamin Budish
Overweight
maintain
$151 -> $154
2025-11-11
Reason
Barclays
Benjamin Budish
Price Target
$151 -> $154
2025-11-11
maintain
Overweight
Reason
Barclays analyst Benjamin Budish raised the firm's price target on KKR to $154 from $151 and keeps an Overweight rating on the shares post the Q3 report. The company's earnings beat with fundraising and deployment "very strong," the analyst tells investors in a research note.
Oppenheimer
Chris Kotowski
Outperform
maintain
$164 -> $166
2025-11-10
Reason
Oppenheimer
Chris Kotowski
Price Target
$164 -> $166
2025-11-10
maintain
Outperform
Reason
Oppenheimer analyst Chris Kotowski raised the firm's price target on KKR to $166 from $164 and keeps an Outperform rating on the shares. The firm says KKR's quarter reads like a masterclass in consistency, with record inflows, disciplined deployment, and an unapologetic reminder that scale, when executed right, is not just a number but a competitive advantage that keeps compounding.
About KKR
KKR & Co. Inc. is a global investment firm that offers alternative asset management as well as capital markets and insurance solutions. The Company’s segments include Asset Management, Insurance and Strategic Holdings. Asset Management segment offers a range of investment management services to investment funds, vehicles and accounts and provides capital markets services to portfolio companies and third parties. Asset Management segment includes five business lines: Private Equity, Real Assets, Credit and Liquid Strategies, Capital Markets and Principal Activities. Insurance segment is operated by Global Atlantic, which is a United States retirement and life insurance company that provides a suite of protection, legacy and savings products and reinsurance solutions to clients across individual and institutional markets. Global Atlantic offers individuals fixed-rate annuities and others. Strategic Holdings segment represents its participation in its core private equity strategy.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
